Clinical trials
Observational Substance-Related Disorders trials in France
Search ClinicalTrials.gov registrations by keyword, then narrow by condition, phase, status, country and start year.
33 trials match Source: ClinicalTrials.gov registrations
Trials started per year
By phase, 2000 to 2026.
| Category | Trials |
|---|---|
| 2008 | 1 |
| 2013 | 1 |
| 2015 | 2 |
| 2017 | 1 |
| 2018 | 4 |
| 2019 | 4 |
| 2020 | 6 |
| 2021 | 4 |
| 2022 | 3 |
| 2023 | 2 |
| 2024 | 1 |
| 2025 | 2 |
| 2026 | 2 |
Status
Trials by registry status. Select a bar to filter.
| Category | Trials |
|---|---|
| Completed | 22 |
| Recruiting | 5 |
| Unknown status | 5 |
| Not yet recruiting | 1 |
Top lead sponsors
A sponsor with a page on Pharma Observatory links to it.
| Category | Trials |
|---|---|
| Nantes University Hospital | 6 |
| University Hospital, Montpellier | 5 |
| Assistance Publique - Hôpitaux de Paris | 3 |
| University Hospital, Clermont-Ferrand | 3 |
| University Hospital, Strasbourg, France | 2 |
| Assistance Publique Hopitaux De Marseille | 1 |
| Centre Hospitalier Charles Perrens, Bordeaux | 1 |
| Centre Hospitalier Universitaire de Nīmes | 1 |
| Centre Hospitalier Universitaire, Amiens | 1 |
| Etablissement Public de Santé Barthélemy Durand | 1 |
Top conditions
MeSH conditions the trials were registered with, not their broader categories. A condition with a page on Pharma Observatory links to it.
| Category | Trials |
|---|---|
| Substance-Related Disorders | 33 |
| Opioid-Related Disorders | 3 |
| Alcoholism | 2 |
| Anxiety Disorders | 2 |
| COVID-19 | 2 |
| Marijuana Abuse | 2 |
| Pain | 2 |
| Wounds and Injuries | 2 |
| Cardiovascular Diseases | 1 |
| Chronic Pain | 1 |
Trials
Showing 1 to 25 of 33. Each trial links to its page on Pharma Observatory.
Recently changed trials
Changes observed in the last 7 days, newest first, site-count changes left out. Source: ClinicalTrials.gov.
No changes to these trials in the last 7 days.
Go deeper on Pharma Observatory
Pharma Observatory connects clinical trials, sponsors, sites and investigators in one searchable platform.